ArticleClinical and translational medicine2016

Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma.

Kimberly J Bussey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.